Step 1: Be Aware, Anxiety Prevention Intervention
Launched by YALE UNIVERSITY · Jun 25, 2025
Trial Information
Current as of October 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is testing a 5-week, community-based program designed to help prevent anxiety in urban youth of color in Paterson, New Jersey. It’s not a drug or medical device. The program is run in schools and through community engagement, with sessions led by trained facilitators who include someone from the local community to keep it culturally relevant. All participants would receive the intervention—there is no comparison group in this single-group design—and researchers will measure anxiety symptoms at baseline, after the five sessions, and about three months later using a short questionnaire called the GAD-7.
About who can join: the study plans to enroll about 50 youths aged 13 to 21 who live in Paterson and can read and speak English, and who give their consent to participate. Key exclusions are not being able to read/write English, not residing in Paterson, or not providing consent. Recruitment will involve collaboration with a local high school. At this stage, the trial is actively enrolling by invitation, with results not yet available. The study is led by Yale University.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • able to speak and read in English
- • reside in Paterson
- Exclusion Criteria:
- • English is not first language and cannot read or write English
- • Does not have residence in Paterson
- • Has not provided consent to participate in study
About Yale University
Yale University, a prestigious Ivy League institution located in New Haven, Connecticut, is renowned for its commitment to advancing medical research and clinical innovation. With a rich history of academic excellence and a robust infrastructure for scientific inquiry, Yale serves as a leading sponsor for clinical trials aimed at improving patient care and developing new therapeutic approaches. The university's multidisciplinary teams of researchers and clinicians collaborate to conduct rigorous and ethical studies, leveraging cutting-edge technologies and methodologies to address critical health challenges. Through its dedication to fostering an environment of inquiry and discovery, Yale University plays a pivotal role in translating research findings into clinical practice, ultimately enhancing health outcomes for diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paterson, New Jersey, United States
Patients applied
Trial Officials
Ijeoma Opara, PhD
Principal Investigator
Yale University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported